Full Text View
Tabular View
No Study Results Posted
Related Studies
A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn’s Disease
This study has been completed.
Study NCT00078611   Information provided by Elan Pharmaceuticals
First Received: March 1, 2004   Last Updated: October 26, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Crohn's Disease
Additional conditions recognized in this trial
Crohn Disease
More general conditions related to this trial
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Inflammatory Bowel Diseases
Intestinal Diseases
Interventions listed in this trial
Antegren(TM) (natalizumab)
Sponsors listed in this trial
Elan Pharmaceuticals
Biogen Idec


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services